Quantcast Mike Terretti's Daily Pharma News
Mike Terretti's Daily Pharma News By Mike Terretti 919-781-0400x112
Mike Terretti’s focus is the Pharmaceutical and Biotechnology Industries in Executive Recruitment. THe following information drives all the growth and opportunity in our market.
Mike Terretti's Daily Pharma News >> PHARMACEUTICAL INDUSTRY November 25, 2009 members login here
Public San Francisco -Global Clinical Research -Oncology 
My Public San Francisco area client is focused on the development and commercialization of novel therapeutics for oncology.
This position in the overall management of the clinical project team and with the development of clinical plans and implementation of clinical trials.
Executive Director, Global Clinical Research and Development-Oncology

Essential functions include, but are not limited to the following:
• Oversee... Read More    Add Comment

More
>>  PHARMACEUTICAL INDUSTRY
Illumina to Present at the Piper Jaffray "Unplugged" Health Care Conference
Forbes.com - 3 Hours ago
BusinessWire - Illumina, Inc. (NASDAQ:ILMN) announced today that the company will webcast its presentation at the Piper Jaffray 'Unplugged' Health Care Conference in New York, New York, on December 2,
Illumina to Present at the Piper Jaffray Globe Investor
BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Therapeutics Daily
all 20 news articles >>      Add Comment

UPDATE 2-Novartis strikes licensing deal with Incyte
Forbes.com - 3 Hours ago
ZURICH, Nov 25 (Reuters) - Swiss drugmaker Novartis has struck a licensing deal with Incyte Corp, paying $150 million up front for access to therapies to treat patients with life-threatening blood disorders
Incyte, Novartis sign collaboration, license agreement for two hematology-oncology Therapeutics Daily
Novartis links up with Incyte in $1.1 billion cancer deal Pharma Times
all 12 news articles >>      Add Comment

Novartis To Develop, Commercialize Two Hematology-oncology Therapies Of Incyte -
RTTNews.com - 6 Hours ago
Optional: Temporarily hide the 'tabber' class so it does not 'flash' on the page as plain HTML. After tabber runs, the class is changed to 'tabberlive' and it will appear. //Function Which Calls Swap
Incyte to license 2 hematology drugs to Novartis MarketWatch
all 1 news articles >>      Add Comment

Cadence Pharmaceuticals Down 12.5% Since SmarTrend's Sell Recomme...
Zibb - 6 Hours ago
Company: Cadence Pharmaceuticals Inc (CADX) SmarTrend, our proprietary pattern recognition system, called a Downtrend for Cadence Pharmaceuticals (NASDAQ:CADX) on August 19, 2009 at $9.83. Since then,
Magnetek Down 15.3% Since SmarTrend's Sell Recommendation Individual.com
Macy's Down 4.2% Since SmarTrend's Sell Recommendation TradingMarkets
all 8 news articles >>      Add Comment

Roche CEO sees group outpacing market in 2009-paper
Reuters - 3 Hours ago
* Roche CEO confident will meet new drugs sales goal * Sees pharma unit gaining market share ZURICH, Nov 25 (Reuters) - Swiss drugmaker Roche's (ROG.VX) pharma and diagnostics units will significantly
     Add Comment

Vaccine-maker tries to assure patients H1N1 doses are safe
Los Angeles Times - 7 Hours ago
Reporting from Allentown, Pa. - Forget the chicken. At vaccine-maker Sanofi Pasteur, it all starts with the egg -- millions of them each week. The mini vaccine factories will grow more than 75 million
     Add Comment

Pfizer says to expand R&D in central, western China
Reuters UK - 8 Hours ago
HONG KONG, Nov 25 (Reuters) - Pfizer Inc (PFE.N) plans to expand its research and development operations in central and western China as it strengthens its biomedical infrastructure throughout the country,
     Add Comment

Merck to buy back up to $3 billion in stock
MENAFN - 7 Hours ago
SAN FRANCISCO (MarketWatch) -- Merck & Co. Inc. said Tuesday it will repurchase up to $3 billion in stock, in a move intended to gather up equity issued recently to help it acquire Schering-Plough. Merck
     Add Comment

UPDATE 1-Roche seeks broader EU breast cancer label for drug
Reuters UK - 8 Hours ago
* EU approval sought for broader Avastin breast cancer use * Application based on study on benefits with chemotherapy ZURICH, Nov 25 (Reuters) - Swiss drugmaker Roche Holding (ROG.VX) has filed for European
     Add Comment

NUCRYST Pharmaceuticals Corp. (NCST) Corporate Event Announcement...
Zibb - 12 Hours ago
Company: NUCRYST Pharmaceuticals Corp (NCST) Copyright (C) 2009 Wall Street Horizon. All rights reserved News Provided by COMTEX Company: NUCRYST Pharmaceuticals Corp (NCST)
     Add Comment

Shire Submits New Gaucher Treatment to EU
Pharmaceutical Technology - 3 Hours ago
Shire has submitted a marketing application to the European Medicines Agency for velaglucerase alfa, a new enzyme replacement therapy to treat type 1 Gaucher disease. The company's application for accelerated
Shire submits Gaucher disease drug in Europe Pharma Times
Shire asks EU for Gaucher drug approval Reuters Health
all 4 news articles >>      Add Comment

Chemielaboranten (m/w) Pharma - Analytik
ChemieKarriere.net - 3 Hours ago
Life Science Network: Suche nach: in: News Suchen Suchziel: Volltext Titel Firmenname Art der Anstellung: Ausbildung Befristete Anstellung Festanstellung Freie Mitarbeit Praktikum Diplomarbeit Dissertation
     Add Comment

Researchers Optimistic Over New Cancer Pain Drug
Pharmaceutical Technology - 3 Hours ago
New research published by GW Pharmaceuticals has given hope that a new pain drug Sativex could provide relief for patients with advanced cancer where pain is not fully relieved by strong opioids. The
     Add Comment

[DUR]-Drug News
Therapeutics Daily - 4 Hours ago
Two children died after surgery and IV solution problems ISMP warns hospitals to educate staff Two young children recently died from severe postoperative hyponatremia, says the Institute for Safe Medication
     Add Comment

UK SMALLCAP ROUNDUP: GW Pharma Posts ...
Morningstar UK - 5 Hours ago
Morningstar.co.uk membership provides you with expert guidance for making better investment decisions. You'll get access to our in-depth fund research, as well as our portfolio and x-ray tool, investment
     Add Comment

Jury awards $34.3M against hormone therapy drug makers
LawyersUSA - 7 Hours ago
against , finding that the drug maker willfully failed to warn patients of cancer risks associated with the hormone replacement drugs Premarin, Provera and . The jury awarded $6.3 million in compensatory
$34.3 million awarded in hormone therapy lawsuit Individual.com
Jury awards $34.3M against hormone therapy drug makers LawyersUSA
all 2 news articles >>      Add Comment

West Pharmaceutical Announces Management Change
PharmaceuticalProcessing - 7 Hours ago
West Pharmaceutical Services, Inc. has announced that the company's Chief Operating Officer Matthew T. Mullarkey has left the company by mutual agreement. Company President and former Chief Operating
West Announces Management Change Pittsburgh Business Times
all 1 news articles >>      Add Comment

Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo Complete
PharmaceuticalProcessing - 7 Hours ago
Transcept Pharmaceuticals, Inc. is scheduled to meet with the FDA on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo (zolpidem tartrate
Transcept Pharmaceuticals Scheduled To Meet With FDA To Discuss Intermezzo(R) Complete Medical News Today
Medical News: Transcept Pharmaceuticals Scheduled To Meet With FDA To Discuss Intermezzo(R) BioFind
all 2 news articles >>      Add Comment

Pfizers pulmonary arterial hypertension med gets FDA nod
HealthImaging - 13 Hours ago
FURTHER READING Organization FDA Topic hypertension The FDA has approved an intravenous form of sildenafil (Revatio; Pfizer), a phosphodiesterase-5 (PDE5) inhibitor for the treatment of in adult
     Add Comment

WSJ UPDATE: Vaccine Makers Struggle To ...
Morningstar UK - 13 Hours ago
UPDATE: Vaccine Makers Struggle To Speed Output gaJsHost (('https:' ? 'https://ssl.' : + gaJsHost + 'google-analytics.com/ga.js' You currently DO NOT have javascript enabled, to view our site this must
WSJ UPDATE: Vaccine Makers Struggle To S... Hemscott
all 1 news articles >>      Add Comment

Pharma Unplugged: Episode #1 - A Link Apart
Pharmaceutical Technology - 13 Hours ago
Click icon to automatically deliver podcasts to your iTunes or rich media player. A Link Apart : FDA Social Media Hearing Pharma Unplugged Podcast Series Sponsors WEBCAST â?? Sponsor (Medpoint) WEBCAST
     Add Comment

Merck to set up $220 mln R & D center in Beijing
Interfax - 14 Hours ago
Shanghai. November 25. INTERFAX-CHINA - Global pharmaceutical giant Merck Serono International S.A. will establish a global research and development (R & D) center in China, the company announced on Nov.
     Add Comment

Kerr Drug stretches horizons for Rx
Chain Drug Review - 15 Hours ago
CHAPEL HILL, N.C. â?? Kerr Drug this month took another step to advance pharmacy. The chain opened a store here with a room for pharmacogenomics, the study of how a patientâ??s genes affect medication
     Add Comment

Drug chains step up marketing efforts
Chain Drug Review - 15 Hours ago
NEW YORK â?? Drug chains across the country and in Canada are stepping up their promotional efforts this holiday season, offering everything from sophisticated catalogs and in-store flyers to money-saving
     Add Comment

Drug import proposal under fire
Chain Drug Review - 15 Hours ago
ALEXANDRIA, Va. â?? The National Association of Chain Drug Stores has expressed concerns with a proposed amendment to health care legislation because the provision would authorize the importation of prescription
     Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.